Cocrystal Pharma Profit Margin

The latest profit margin for COCP is -9464.76% as of June 2026. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Cocrystal Pharma's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, COCP currently prints -9464.76% for profit margin, while the sector average sits near 13.89%. That is roughly 68240.1% below the sector mean. Large gaps often invite a closer look at Cocrystal Pharma's growth, margins, and balance sheet.

Profit Margin shows how effectively Cocrystal Pharma converts resources into returns. At -9464.76%, COCP may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting COCP's profit margin (-9464.76%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Cocrystal Pharma's profit margin against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.